> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Debars Physician Who Bought Drugs from Canada
- URL: https://www.fdaweb.com/fda-debars-physician-who-bought-drugs-from-canada/
- Published: 2018-12-10T12:00:00.000Z
- Updated: 2026-09-15T00:49:49.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142996

*Federal Register* notice: FDA has issued an order debarring **David J. Fishman** for three years from providing services in any capacity to a person that has an approved or pending drug product application. The order is based on a finding that Fishman was convicted of a misdemeanor for causing the introduction or delivery for introduction into interstate commerce of prescription drugs that were misbranded. In 2013, he entered a guilty plea to one count of misbranding for his role as a physician in purchasing drugs, including docetaxel and mitoxantrone, from a drug distributor located in Canada. Because the drugs originated outside the U.S., they were not approved by FDA. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-26722.pdf?ref=fdaweb.com).